Shah Preetam

Number of records: 12
SEC FilingCompany/StockTrade DateTransactionSharesAvg. PriceTotal% HoldingsGain/Loss
20-Mar-24 6:48 PM
View: 
Cidara Therapeutics, Inc. (CDTX) 15-Mar-24Grant 108,750----48%
227.21K to 335.96K
12-Mar-24 9:45 PM
View: 
Cidara Therapeutics, Inc. (CDTX) 11-Mar-24Sale 18,931$0.67$12,680.00(8%)
246.14K to 227.21K
29-Mar-23 5:24 PM
View: 
Cidara Therapeutics, Inc. (CDTX) 27-Mar-23Grant 90,000----61%
148.14K to 238.14K
13-Mar-23 9:20 PM
View: 
Cidara Therapeutics, Inc. (CDTX) 13-Mar-23Private Sale 6,648$1.53$10,171.40(4%)
154.79K to 148.14K
19-Sep-22 8:28 PM
View: 
Cidara Therapeutics, Inc. (CDTX) 19-Sep-22Option Sale 15,642$0.77$12,035.00(9%)
166.43K to 150.79K
19-Sep-22 8:28 PM
View: 
Cidara Therapeutics, Inc. (CDTX) 15-Sep-22Option Exercise 50,000----43%
116.43K to 166.43K
04-Apr-22 5:21 PM
View: 
Cidara Therapeutics, Inc. (CDTX) 31-Mar-22Grant 117,251----586%
20.0K to 137.25K
04-Apr-22 5:21 PM
View: 
Cidara Therapeutics, Inc. (CDTX) 31-Mar-22Payment of Exercise 24,820$0.83$20,600.60(18%)
137.25K to 112.43K
15-Nov-21 6:38 PM
View: 
Cidara Therapeutics, Inc. (CDTX) 12-Nov-21Market Purchase 20,000$1.54$30,800.00100%
0 to 20.0K
5%
31-Dec-20 9:20 PM
View: 
Brainstorm Cell Therapeutic... (BCLI) 30-Dec-20Payment of Exercise 25,000$4.64$116,000.00(68%)
36.6K to 11.6K
< 1%
27-Dec-19 7:01 AM
View: 
Brainstorm Cell Therapeutic... (BCLI) 24-Dec-19Market Purchase 11,600$3.96$45,929.0046%
25.0K to 36.6K
(7%)
09-Sep-19 8:00 AM
View: 
Brainstorm Cell Therapeutic... (BCLI) 06-Sep-19Grant 25,000----100%
0 to 25.0K